Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
115 studies found for:    Open Studies | "Malaria"
Show Display Options
Rank Status Study
21 Recruiting Screening of Healthy Volunteers for Investigational Antimalarial Drugs, Malaria Vaccines, and Controlled Human Malaria Challenge
Condition: Malaria
Intervention:
22 Recruiting A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, Administered With and Without Matrix-M1
Condition: Malaria
Interventions: Biological: R21;   Biological: Matrix-M1
23 Recruiting A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B
Condition: Malaria
Intervention: Biological: R21 with ASO1B
24 Recruiting A Study to Assess the Safety and Immunogenicity of the Malaria Vaccine, R21, With Matrix-M1 Adjuvant
Condition: Malaria
Interventions: Biological: R21/Matrix-M1;   Other: Saline
25 Recruiting A Study to Assess the Safety and Immunogenicity of a Candidate Malaria Vaccine Using Novel Routes of Administration
Condition: Malaria
Intervention: Biological: ChAd63-METRAP
26 Recruiting Evaluation of Long-Lasting Microbial Larvicides in Reducing Malaria Transmission and Clinical Malaria Incidence
Condition: Malaria
Intervention: Biological: Fourstar® granule, 90 day and 180 day briquettes Bti/Bs
27 Not yet recruiting Artemeter-lumefantrine for Treatment of P. Falciparum Malaria in Brazil
Condition: Malaria
Intervention: Drug: Artemether-lumefantrine combination
28 Not yet recruiting Malaria Vaccine Safety and Immunogenicity Study in Healthy Adults
Condition: Malaria Vaccine
Interventions: Biological: RTS,S/AS01B Fractional dose;   Biological: Double RTS,S/AS01E Fractional dose;   Biological: RTS,S/AS01E Standard dose;   Biological: RTS,S/AS01E + DHA-PIP+PQ Standard dose;   Biological: RTS,S/AS01E Fractional dose;   Biological: RTS,S/AS01E + DHA-PIP+PQ Fractional dose;   Biological: RTS,S/AS01E + DHA-PIP+PQ Fractional two-dose
29 Not yet recruiting MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria
Condition: Malaria
Intervention: Drug: MMV390048
30 Recruiting IMPROV (Improving the Radical Cure of Vivax Malaria)
Condition: Uncomplicated Vivax Malaria
Interventions: Drug: Primaquine;   Drug: Placebo
31 Recruiting A Pharmacokinetics, Safety and Efficacy Study of Tafenoquine (TQ) in Pediatric Subjects With Plasmodium Vivax (P. Vivax) Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Chloroquine
32 Not yet recruiting G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria
Condition: Vivax Malaria
Interventions: Drug: Chloroquine;   Drug: Primaquine 0.25 mg/kg/day;   Drug: Primaquine 0.75 mg/kg weekly
33 Not yet recruiting Methylene Blue Against Vivax Malaria in Ethiopia
Condition: Vivax Malaria
Interventions: Drug: Artemeter-Lumefantrine and MB (combination therapy);   Drug: Artemeter-Lumefantrine (combination therapy);   Drug: Artemeter-Lumefantrine and Primaquine (combination therapy)
34 Not yet recruiting Severe and Cerebral Malaria Investigated Through Host Metabolomics
Condition: Severe Malaria
Intervention: Other: Observation
35 Not yet recruiting A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)
Condition: Uncomplicated Malaria
Interventions: Drug: PQ supervised;   Drug: PQ unsupervised
36 Recruiting Imatinib's Effect on the Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria
Condition: Plasmodium Falciparum Malaria
Interventions: Drug: Imatinib;   Drug: Dihydroartemisinin-piperaquine
37 Not yet recruiting Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria
Condition: Malaria, Vivax
Interventions: Drug: Tafenoquine;   Drug: Matched-Placebo for Tafenoquine;   Drug: Primaquine;   Drug: Matched-Placebo for Primaquine;   Drug: Dihydroartemisinin-piperaquine (DHA-PQP);   Drug: ACT plus PQ (Rescue medication);   Drug: PQ (End of study treatment)
38 Recruiting Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
Condition: Malaria, Vivax
Intervention: Drug: Eurartesim tablets
39 Recruiting Targeted Chemo-elimination (TCE) of Malaria
Condition: Plasmodium Falciparum Malaria
Intervention: Drug: malaria elimination using DP and low-dose primaquine
40 Recruiting Malaria in Early Life Study
Conditions: Plasmodium Falciparum Malaria;   Plasmodium Vivax Malaria
Intervention: Drug: dihydroartemisinin-piperaquine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.